ScreenIn3D Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$985K
- Investors
-
10
ScreenIn3D General Information
Description
Developer of advanced drug screening technologies and software designed to de-risk drug discovery. The company leverages microfluidic technology to generate physiologically relevant three-dimensional models of human disease, enabling pharmaceutical and biotechnology professionals to conduct throughput drug screening, reduce costs, and accelerate the drug discovery process using predictive, animal-free disease models.
Contact Information
Website
www.screenin3d.comCorporate Office
- Technology and Innovation Centre
- 99 George Street
- Glasgow G1 1RD
- Scotland, United Kingdom
Corporate Office
- Technology and Innovation Centre
- 99 George Street
- Glasgow G1 1RD
- Scotland, United Kingdom
ScreenIn3D Timeline
ScreenIn3D Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 12-Jun-2025 | $985K | Completed | Generating Revenue | ||
| 4. Seed Round | 28-Jul-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Grant | 01-Jun-2022 | $211K | Completed | Generating Revenue | ||
| 1. University Spin-Out | 22-Nov-2018 | Completed | Startup |
ScreenIn3D Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ScreenIn3D Patents
ScreenIn3D Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4508188-A1 | Microfluidic apparatus | Pending | 14-Apr-2022 | ||
| GB-202205532-D0 | Microfluidic apparatus | Inactive | 14-Apr-2022 | ||
| US-20250257301-A1 | Microfluidic apparatus | Pending | 14-Apr-2022 | ||
| WO-2023199018-A1 | Microfluidic apparatus | Inactive | 14-Apr-2022 | ||
| US-11179719-B2 | Microfluidic device | Active | 13-Apr-2017 | B01L3/50273 |
ScreenIn3D Signals
ScreenIn3D Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gabriel Investments | Venture Capital | Minority | ||
| Nidobirds Ventures | Venture Capital | Minority | ||
| Shancastle Investments | Corporation | Minority | ||
| TRICAPITAL Angel Investors | Angel Group | Minority | ||
| Gabriel Investment Syndicate | Angel Group | Minority |
ScreenIn3D FAQs
-
When was ScreenIn3D founded?
ScreenIn3D was founded in 2018.
-
Where is ScreenIn3D headquartered?
ScreenIn3D is headquartered in Glasgow, United Kingdom.
-
What is the size of ScreenIn3D?
ScreenIn3D has 7 total employees.
-
What industry is ScreenIn3D in?
ScreenIn3D’s primary industry is Drug Discovery.
-
Is ScreenIn3D a private or public company?
ScreenIn3D is a Private company.
-
What is the current valuation of ScreenIn3D?
The current valuation of ScreenIn3D is .
-
What is ScreenIn3D’s current revenue?
The current revenue for ScreenIn3D is .
-
How much funding has ScreenIn3D raised over time?
ScreenIn3D has raised $1.27M.
-
Who are ScreenIn3D’s investors?
Gabriel Investments, Nidobirds Ventures, Shancastle Investments, TRICAPITAL Angel Investors, and Gabriel Investment Syndicate are 5 of 10 investors who have invested in ScreenIn3D.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process